Cargando…

Comparing molecular and computational approaches for detecting viral integration of AAV gene therapy constructs

Many current gene therapy targets use recombinant adeno-associated virus (AAV). The majority of delivered AAV therapeutics persist as episomes, separate from host DNA, yet some viral DNA can integrate into host DNA in different proportions and at genomic locations. The potential for viral integratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oziolor, Elias M., Kumpf, Steven W., Qian, Jessie, Gosink, Mark, Sheehan, Mark, Rubitski, David M., Newman, Leah, Whiteley, Laurence O., Lanz, Thomas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209688/ https://www.ncbi.nlm.nih.gov/pubmed/37251978 http://dx.doi.org/10.1016/j.omtm.2023.04.009

Ejemplares similares

Biodistribution and Tolerability of AAV-PHP.B-CBh-SMN1 in Wistar Han Rats and Cynomolgus Macaques Reveal Different Toxicologic Profiles
por: Palazzi, Xavier, et al.
Publicado: (2022)

Targeting the somatosensory system with AAV9 and AAV2retro viral vectors
por: Skorput, Alexander G. J., et al.
Publicado: (2022)

Annotation depth confounds direct comparison of gene expression across species
por: Oziolor, Elias, et al.
Publicado: (2021)

ToxReporter: viewing the genome through the eyes of a toxicologist
por: Gosink, Mark
Publicado: (2016)

Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action
por: Lanz, Thomas A, et al.
Publicado: (2013)

Identification of tubular injury microRNA biomarkers in urine: comparison of next-generation sequencing and qPCR-based profiling platforms
por: Nassirpour, Rounak, et al.
Publicado: (2014)

Evolutionary toxicology in an omics world
por: Oziolor, Elias M., et al.
Publicado: (2017)

Viral and Cellular Components of AAV2 Replication Compartments
por: Vogel, Rebecca, et al.
Publicado: (2013)

Optimization of AAV vectors to target persistent viral reservoirs
por: Colón-Thillet, Rossana, et al.
Publicado: (2021)

Construction of an rAAV Producer Cell Line through Synthetic Biology
por: Lee, Zion, et al.
Publicado: (2022)

Organocatalyst treatment improves variant calling and mutant detection in archival clinical samples
por: Wehmas, Leah C., et al.
Publicado: (2022)

Construction of PR39 recombinant AAV under control of the HRE promoter and the effect of recombinant AAV on gene therapy of ischemic heart disease
por: SUN, LIJUN, et al.
Publicado: (2012)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018)

ToxEvaluator: an integrated computational platform to aid the interpretation of toxicology study-related findings
por: Pelletier, D., et al.
Publicado: (2016)

Novel human liver-tropic AAV variants define transferable domains that markedly enhance the human tropism of AAV7 and AAV8
por: Cabanes-Creus, Marti, et al.
Publicado: (2021)

AAV ANCESTRAL RECONSTRUCTION LIBRARY ENABLES SELECTION OF BROADLY INFECTIOUS VIRAL VARIANTS
por: Santiago-Ortiz, Jorge, et al.
Publicado: (2015)

AAV1 is the optimal viral vector for optogenetic experiments in pigeons (Columba livia)
por: Rook, Noemi, et al.
Publicado: (2021)

Novel approaches to render stable producer cell lines viable for the commercial manufacturing of rAAV-based gene therapy vectors
por: Emmerling, Verena V, et al.
Publicado: (2013)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)

Rational Design of AAV-rh74, AAV3B, and AAV8 with Limited Liver Targeting
por: Chan, Christopher, et al.
Publicado: (2023)

The Structure of an AAV5-AAVR Complex at 2.5 Å Resolution: Implications for Cellular Entry and Immune Neutralization of AAV Gene Therapy Vectors
por: Silveria, Mark A., et al.
Publicado: (2020)

Mutants at the 2-Fold Interface of Adeno-associated Virus Type 2 (AAV2) Structural Proteins Suggest a Role in Viral Transcription for AAV Capsids
por: Aydemir, Fikret, et al.
Publicado: (2016)

The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner
por: Gonzalez-Sandoval, Adriana, et al.
Publicado: (2023)

Computational and molecular tools for scalable rAAV-mediated genome editing
por: Stoimenov, Ivaylo, et al.
Publicado: (2015)

An Experimental and Computational Evolution-Based Method to Study a Mode of Co-evolution of Overlapping Open Reading Frames in the AAV2 Viral Genome
por: Kawano, Yasuhiro, et al.
Publicado: (2013)

Successful Transduction with AAV Vectors after Selective Depletion of Anti-AAV Antibodies by Immunoadsorption
por: Orlowski, Alejandro, et al.
Publicado: (2020)

AAV process intensification by perfusion bioreaction and integrated clarification
por: Mendes, João P., et al.
Publicado: (2022)

Preferred transduction with AAV8 and AAV9 via thalamic administration in the MPS IIIB model: A comparison of four rAAV serotypes
por: Gilkes, J.A., et al.
Publicado: (2015)

AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
por: Hui, Daniel J, et al.
Publicado: (2015)

Comparative Analysis of DNA Nanoparticles and AAVs for Ocular Gene Delivery
por: Han, Zongchao, et al.
Publicado: (2012)

Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line
por: Stiefelhagen, Marius, et al.
Publicado: (2008)

A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for Interpretation
por: Stafford, Imogen S, et al.
Publicado: (2022)

Adeno-Associated Virus Receptor-Binding: Flexible Domains and Alternative Conformations through Cryo-Electron Tomography of Adeno-Associated Virus 2 (AAV2) and AAV5 Complexes
por: Hu, Guiqing, et al.
Publicado: (2022)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2016)

Humoral Immune Response to AAV
por: Calcedo, Roberto, et al.
Publicado: (2013)

The X Gene of Adeno-Associated Virus 2 (AAV2) Is Involved in Viral DNA Replication
por: Cao, Maohua, et al.
Publicado: (2014)

Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy – current and future perspectives
por: Prakoso, Darnel, et al.
Publicado: (2021)

Induction of ER Stress by an AAV5 BDD FVIII Construct Is Dependent on the Strength of the Hepatic-Specific Promoter
por: Fong, Sylvia, et al.
Publicado: (2020)

Ectopic insert-dependent neuronal expression of GFAP promoter-driven AAV constructs in adult mouse retina
por: Le, Nguyet, et al.
Publicado: (2022)

Current Best Practice in the Management of Varicose Veins
por: Whiteley, Mark Steven
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b4qu8fncbequ09epcbjpg2qogb